China
· Delayed Price · Currency is CNY BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of CNY 181.32 billion. The enterprise value is 170.38 billion.
| Market Cap | 181.32B |
| Enterprise Value | 170.38B |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 115.06M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.47% |
| Shares Change (QoQ) | +4.62% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 69.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 74.09 |
| PS Ratio | 5.98 |
| PB Ratio | 7.14 |
| P/TBV Ratio | 7.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 117.85 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -59.84 |
| EV / Sales | 5.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -130.10 |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.96 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.52 |
| Interest Coverage | -15.99 |
Financial Efficiency
Return on equity (ROE) is -11.44% and return on invested capital (ROIC) is -4.16%.
| Return on Equity (ROE) | -11.44% |
| Return on Assets (ROA) | -3.22% |
| Return on Invested Capital (ROIC) | -4.16% |
| Return on Capital Employed (ROCE) | -7.69% |
| Revenue Per Employee | 2.75M |
| Profits Per Employee | -258,837 |
| Employee Count | 11,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.19% in the last 52 weeks. The beta is 0.49, so BeiGene's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +70.19% |
| 50-Day Moving Average | 233.37 |
| 200-Day Moving Average | 181.45 |
| Relative Strength Index (RSI) | 47.42 |
| Average Volume (20 Days) | 2,456,641 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, BeiGene had revenue of CNY 30.30 billion and -2.85 billion in losses. Loss per share was -26.87.
| Revenue | 30.30B |
| Gross Profit | 25.70B |
| Operating Income | -2.15B |
| Pretax Income | -1.95B |
| Net Income | -2.85B |
| EBITDA | -885.34M |
| EBIT | -2.15B |
| Loss Per Share | -26.87 |
Balance Sheet
The company has 18.26 billion in cash and 7.23 billion in debt, giving a net cash position of 11.03 billion.
| Cash & Cash Equivalents | 18.26B |
| Total Debt | 7.23B |
| Net Cash | 11.03B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.39B |
| Book Value Per Share | 235.25 |
| Working Capital | 13.88B |
Cash Flow
In the last 12 months, operating cash flow was 1.54 billion and capital expenditures -2.85 billion, giving a free cash flow of -1.31 billion.
| Operating Cash Flow | 1.54B |
| Capital Expenditures | -2.85B |
| Free Cash Flow | -1.31B |
| FCF Per Share | n/a |
Margins
Gross margin is 84.81%, with operating and profit margins of -7.10% and -9.40%.
| Gross Margin | 84.81% |
| Operating Margin | -7.10% |
| Pretax Margin | -6.43% |
| Profit Margin | -9.40% |
| EBITDA Margin | -2.92% |
| EBIT Margin | -7.10% |
| FCF Margin | n/a |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.47% |
| Shareholder Yield | -1.47% |
| Earnings Yield | -1.57% |
| FCF Yield | -0.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 4.11.
| Altman Z-Score | 4.11 |
| Piotroski F-Score | n/a |